-
Signature
-
/s/ Raphael Deferiere, attorney-in-fact
-
Issuer symbol
-
CNTA
-
Transactions as of
-
08 Dec 2025
-
Net transactions value
-
-$252,350
-
Form type
-
4
-
Filing time
-
08 Dec 2025, 18:26:06 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Accardi Mario Alberto |
President, Orexin Program |
C/O CENTESSA PHARMACEUTICALS PLC, 3RD FL., 1 ASHLEY RD, ALTRINCHAM, CHESHIRE, UNITED KINGDOM |
/s/ Raphael Deferiere, attorney-in-fact |
08 Dec 2025 |
0002074392 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CNTA |
Ordinary Shares |
Options Exercise |
$47,650 |
+5,000 |
+2.6% |
$9.53 |
198,801 |
08 Dec 2025 |
Direct |
F1 |
| transaction |
CNTA |
Ordinary Shares |
Sale |
$300,000 |
-10,000 |
-5% |
$30.00 |
188,801 |
08 Dec 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CNTA |
Share Option (right to buy) |
Options Exercise |
$0 |
-5,000 |
-44% |
$0.000000 |
6,250 |
08 Dec 2025 |
Ordinary Shares |
5,000 |
$9.53 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: